Results 241 to 250 of about 147,853 (304)

Dual-engineering metalloimmunotherapy mediates <i>Staphylococcus aureus</i> virulence silencing and biofilm immune microenvironment reprogramming against implant-associated infections. [PDF]

open access: yesBioact Mater
Jiang F   +17 more
europepmc   +1 more source

In-Situ Forming Polyester Implants for Sustained Intravesical Oxybutynin Release. [PDF]

open access: yesPharmaceutics
Hartig MU   +3 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Drug delivery from ocular implants

Expert Opinion on Drug Delivery, 2006
Developing an intraocular drug delivery system (DDS) is urgently needed because most vitreoretinal diseases are refractory to conventional pharmacological approaches; eye drops and systemically administered drugs cannot deliver therapeutic drug concentrations into vitreoretinal tissue. Intraocular DDSs address this problem.
Tsutomu Yasukawa   +2 more
exaly   +3 more sources

Implantable Drug Delivery System

International Journal of Multidisciplinary Research and Growth Evaluation
In this paper, we present a shape-programmable magnetically actuated soft capsule robot for semiim plan table drug delivery applications. The shape of the proposed soft capsule is changed by an external magnetic field. To change the robot shape by an external permanent magnet, the relevant soft robot design features and required conditions are ...
S. Upadhyay   +6 more
  +7 more sources

Drug-implantable cardioverter–defibrillator interactions

Expert Review of Cardiovascular Therapy, 2010
Antiarrhythmic drugs are commonly used synergistically with implantable cardioverter defibrillators in the management of ventricular and supraventricular arrhythmias. However, these drugs may directly or indirectly interact with device function. In addition, expanding indications for implantable cardioverter defibrillators, particularly in patients ...
Roger, Beadle   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy